Literature DB >> 25427907

Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma.

Colin T Shearn1, Dennis R Petersen.   

Abstract

The tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a phosphatidylinositol (PtdIns) phosphatase that regulates Akt activation via PtdIns 3 kinase. Changes in PTEN expression and/or activity have been identified in a variety of chronic hepatocellular disorders including obesity, NAFLD, NASH, and alcoholism. In cancer biology, PTEN is frequently mutated or deleted in a wide variety of tumors. Mutations, decreased promoter activity, and decreased expression in PTEN are frequently identified in patients with hepatocellular carcinoma. While the majority of research on PTEN concerns obesity and NASH, PTEN clearly has a role in hepatic insulin sensitivity and in the development of steatosis during chronic alcoholism. Yet, in chronic alcoholics and HCC, very little is known concerning PTEN mutation/deletion or low PTEN expression. This review is focused on an overview of the current knowledge on molecular mechanisms of dysregulation of PTEN expression/activity in the liver and their relationship to development of ethanol-induced hepatocellular damage and cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25427907     DOI: 10.1007/978-3-319-09614-8_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients.

Authors:  Aiman Obed; Steffen Stern; Anwar Jarrad; Thomas Lorf
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.

Authors:  Qi Wang; Wan-Ni Yu; Xinyu Chen; Xiao-Ding Peng; Sang-Min Jeon; Morris J Birnbaum; Grace Guzman; Nissim Hay
Journal:  Cancer Cell       Date:  2016-03-17       Impact factor: 31.743

3.  H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.

Authors:  Ting Liu; Jing Chen; Shuai Xiao; Xiong Lei
Journal:  Tumour Biol       Date:  2015-12-02

Review 4.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

5.  Clinical impact of PTEN methylation status as a prognostic marker for breast cancer.

Authors:  Amal Ramadan; Maha Hashim; Amr Abouzid; Menha Swellam
Journal:  J Genet Eng Biotechnol       Date:  2021-05-10

6.  Insulin Increases Sestrin 2 Content by Reducing Its Degradation through the PI 3 K/mTOR Signaling Pathway.

Authors:  Dandan Chai; Guoyu Wang; Ziyu Zhou; Hanyan Yang; Zhiwen Yu
Journal:  Int J Endocrinol       Date:  2015-02-22       Impact factor: 3.257

Review 7.  Targeting Hepatocellular Carcinoma: What did we Discover so Far?

Authors:  Ana Filipa Brito; Ana Margarida Abrantes; José Guilherme Tralhão; Maria Filomena Botelho
Journal:  Oncol Rev       Date:  2016-10-10

8.  Characterization of aptamer-mediated gene delivery system for liver cancer therapy.

Authors:  Zhongbing Liu; Xiaoduan Sun; Shuangli Xiao; Yan Lin; Chunhong Li; Na Hao; Meiling Zhou; Ruolan Deng; Siyun Ke; Zhirong Zhong
Journal:  Oncotarget       Date:  2017-12-21

9.  Liver-Specific Deletion of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Significantly Ameliorates Chronic EtOH-Induced Increases in Hepatocellular Damage.

Authors:  Colin T Shearn; David J Orlicky; Rebecca L McCullough; Hua Jiang; Kenneth N Maclean; Kelly E Mercer; Bangyan L Stiles; Laura M Saba; Martin J Ronis; Dennis R Petersen
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

Review 10.  Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.

Authors:  Saleh Daher; Muhammad Massarwa; Ariel A Benson; Tawfik Khoury
Journal:  J Clin Transl Hepatol       Date:  2017-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.